Z-DEVD-FMK

For research use only. Not for therapeutic Use.

  • CAT Number: I002617
  • CAS Number: 210344-95-9
  • Molecular Formula: C30H41FN4O12
  • Molecular Weight: 668.70
  • Purity: ≥95%
Inquiry Now

Z-DEVD-FMK (Cat No.:I002617) is a synthetic peptide-based compound that acts as an inhibitor of caspase-3, a key enzyme involved in the process of apoptosis (programmed cell death). It belongs to the class of peptide-based caspase inhibitors known as FMKs (fluoromethylketones). Z-DEVD-FMK specifically targets the active site of caspase-3, irreversibly inhibiting its activity and preventing the activation of downstream apoptotic pathways. This compound is commonly used in laboratory research to study the role of caspase-3 in cellular processes, apoptosis-related diseases, and to explore potential therapeutic interventions targeting apoptosis.


Catalog Number I002617
CAS Number 210344-95-9
Synonyms

methyl (4S)-5-[[(2S)-1-[[(3S)-5-fluoro-1-methoxy-1,4-dioxopentan-3-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-[[(2S)-4-methoxy-4-oxo-2-(phenylmethoxycarbonylamino)butanoyl]amino]-5-oxopentanoate

Molecular Formula C30H41FN4O12
Purity ≥95%
Target Caspase
Solubility 10 mM in DMSO
Storage Store at -20°C
IUPAC Name methyl (4S)-5-[[(2S)-1-[[(3S)-5-fluoro-1-methoxy-1,4-dioxopentan-3-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-[[(2S)-4-methoxy-4-oxo-2-(phenylmethoxycarbonylamino)butanoyl]amino]-5-oxopentanoate
InChI InChI=1S/C30H41FN4O12/c1-17(2)26(29(42)33-20(22(36)15-31)13-24(38)45-4)35-27(40)19(11-12-23(37)44-3)32-28(41)21(14-25(39)46-5)34-30(43)47-16-18-9-7-6-8-10-18/h6-10,17,19-21,26H,11-16H2,1-5H3,(H,32,41)(H,33,42)(H,34,43)(H,35,40)/t19-,20-,21-,26-/m0/s1
InChIKey GBJVAVGBSGRRKN-JYEBCORGSA-N
SMILES CC(C)[C@@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](CCC(=O)OC)NC(=O)[C@H](CC(=O)OC)NC(=O)OCC1=CC=CC=C1
Reference

<p style=/line-height:25px/>
<br>[1]. Rickers A, et al. Inhibition of CPP32 blocks surface IgM-mediated apoptosis and D4-GDI cleavage in human BL60 Burkitt lymphoma cells. Eur J Immunol. 1998, (1), 296-304.
<br>[2]. Yakovlev AG, et al. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci. 1997, 17(19), 7415-7424.
<br>[3]. Wang J, et al. Involvement of caspase 3- and 8-like proteases in ceramide-induced apoptosis of cardiomyocytes. J Card Fail. 2000, 6(3), 243-249.
<br>[4]. Kanthasamy AG, et al. A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson/’s disease models. Free Radic Biol Med. 2006, 41(10), 1578-1589.
</p>

Request a Quote